Oxaliplatin and Clostridium colitis - a phase IV clinical study of FDA data

Summary:

Clostridium colitis is reported as a side effect among people who take Oxaliplatin (oxaliplatin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Fluorouracil, and have Rectal cancer.

The phase IV clinical study analyzes which people have Clostridium colitis when taking Oxaliplatin. It is created by eHealthMe based on reports of 71,972 people who have side effects when taking Oxaliplatin from the FDA, and is updated regularly.

What is Oxaliplatin?

Oxaliplatin has active ingredients of oxaliplatin. It is often used in colon cancer. eHealthMe is studying from 72,058 Oxaliplatin users. Check the latest studies of Oxaliplatin.

What is Clostridium colitis?

Clostridium colitis (inflammation of colon by clostridium difficile bacteria infection) is found to be associated with 238 drugs and 503 conditions by eHealthMe. Check the latest studies of Clostridium colitis.

On Aug, 02, 2026

71,972 people reported to have side effects when taking Oxaliplatin.
Among them, 20 people (0.03%) have Clostridium colitis.

Could Oxaliplatin cause Clostridium colitis?

Among these 20 people:

How long have people been on Oxaliplatin when they have Clostridium colitis? *

What is the gender of people who have Clostridium colitis when taking Oxaliplatin? *

female: 68.42 %
male: 31.58 %

What is the age of people who have Clostridium colitis when taking Oxaliplatin? *

What are other drugs people take besides Oxaliplatin? *

What are other side effects people have besides Clostridium colitis? *

Sepsis (a severe blood infection that can lead to organ failure and death): 11 people, 55.00%
Aplasia (defective development or congenital absence of an organ or tissue): 10 people, 50.00%
Fever: 10 people, 50.00%
Diarrhea: 10 people, 50.00%
Neuropathy Peripheral (surface nerve damage): 10 people, 50.00%
Disease Progression: 5 people, 25.00%
Drug Ineffective: 5 people, 25.00%
Dehydration (dryness resulting from the removal of water): 3 people, 15.00%
Hyperkalemia (damage to or disease of the kidney): 2 people, 10.00%
Weakness: 2 people, 10.00%

What are the existing conditions these people have? *

Rectal Cancer (cancer of rectum): 10 people, 50.00%
Metastatic Neoplasm (spreadable cancer tumour): 1 person, 5.00%
Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 1 person, 5.00%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Oxaliplatin and have Clostridium colitis?

- Check whether Clostridium colitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oxaliplatin:

Oxaliplatin (72,058 reports)

Browse all side effects of Oxaliplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Clostridium colitis:

Clostridium colitis (238 drugs)

Browse all the conditions that are associated with Clostridium colitis:

Clostridium colitis (503 conditions)

Related publications that referenced our studies

Kim HJ, An SH, Cho YH, Kim SY, Lee HG, Yoon SY, "Oxaliplatin-induced Torsades de pointes and long QT syndrome in a patient with gastric cancer", Acta Oncologica, 2013 Aug .
Wang JH, King TM, Chang MC, Hsu CW, "Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis", World journal of gastroenterology: WJG, 2012 Oct .
Kim HJ, An SH, Cho YH, Kim SY, Lee HG, Yoon SY, "Oxaliplatin-induced Torsades de pointes and long QT syndrome in a patient with gastric cancer", Acta Oncologica, 2013 Aug .
Wang JH, King TM, Chang MC, Hsu CW, "Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis", World journal of gastroenterology: WJG, 2012 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on oxaliplatin (the active ingredients of Oxaliplatin) and Oxaliplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.